The company's platform uses silicon nanopore chips and proprietary biochemistry to accurately detect and differentiate single molecules, making it useful in human and animal diagnostics, agriculture, food safety testing, environmental monitoring, and more. Ontera's biosensor offers integrated, ready-to-use solid-state nanopore measurement systems and point-of-care diagnostic devices, allowing clients to perform digital, single-molecule sensing in a small, inexpensive, and easy-to-use form factor in telemedicine. The company aims to transform point-of-care testing and third generation sequencing.